US Patent 10947317 NaPi2b-targeted antibody-drug conjugates and methods of use thereof
Patent 10947317 was granted and assigned to Mersana Therapeutics on March, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 13, 2017
0
Date of Patent
March 16, 2021
0
Patent Applicant
Patent Application Number
15457574
0
Patent Citations Received
Patent Inventor Names
Timothy B. Lowinger
0
Aleksandr V. Yurkovetskiy
0
Donald A. Bergstrom
0
Laura L. Poling
0
Natalya D. Bodyak
0
Peter U. Park
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10947317 NaPi2b-targeted antibody-drug conjugates and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
